11-ketotestosterone has been researched along with Cancer of Prostate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dušková, M; Stárka, L; Vítků, J | 1 |
| Bloem, LM; du Toit, T; Gent, R; Swart, AC | 1 |
| Auchus, RJ; Turcu, AF | 1 |
1 review(s) available for 11-ketotestosterone and Cancer of Prostate
| Article | Year |
|---|---|
11-Keto-testosterone and other androgens of adrenal origin.
Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Animals; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Testosterone | 2020 |
2 other study(ies) available for 11-ketotestosterone and Cancer of Prostate
| Article | Year |
|---|---|
The 11β-hydroxysteroid dehydrogenase isoforms: pivotal catalytic activities yield potent C11-oxy C
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Androstenes; Biosynthetic Pathways; Cell Line, Tumor; HEK293 Cells; Humans; Male; Progesterone; Prostatic Neoplasms; Protein Isoforms; Substrate Specificity; Testosterone | 2019 |
Clinical significance of 11-oxygenated androgens.
Topics: Adrenal Hyperplasia, Congenital; Biomarkers; Diagnostic Techniques, Endocrine; Female; Humans; Male; Patient-Centered Care; Polycystic Ovary Syndrome; Precision Medicine; Predictive Value of Tests; Prostatic Neoplasms; Testosterone | 2017 |